DE69615551T2 - Verwendung einer zubereitung enthaltend amoxycillin und clavulansäure zur herstellung eines medikaments zur behandlung von bakteriellen infektionen bei pädiatrischen patienten - Google Patents

Verwendung einer zubereitung enthaltend amoxycillin und clavulansäure zur herstellung eines medikaments zur behandlung von bakteriellen infektionen bei pädiatrischen patienten

Info

Publication number
DE69615551T2
DE69615551T2 DE69615551T DE69615551T DE69615551T2 DE 69615551 T2 DE69615551 T2 DE 69615551T2 DE 69615551 T DE69615551 T DE 69615551T DE 69615551 T DE69615551 T DE 69615551T DE 69615551 T2 DE69615551 T2 DE 69615551T2
Authority
DE
Germany
Prior art keywords
producing
bacterial infections
preparation containing
medicinal product
clavulanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Revoked
Application number
DE69615551T
Other languages
English (en)
Other versions
DE69615551D1 (de
Inventor
Peregrine Bax
Gale Ramsey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Ltd
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306975&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69615551(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9508989.2A external-priority patent/GB9508989D0/en
Priority claimed from GBGB9523655.0A external-priority patent/GB9523655D0/en
Application filed by SmithKline Beecham Ltd, SmithKline Beecham Corp filed Critical SmithKline Beecham Ltd
Publication of DE69615551D1 publication Critical patent/DE69615551D1/de
Application granted granted Critical
Publication of DE69615551T2 publication Critical patent/DE69615551T2/de
Anticipated expiration legal-status Critical
Revoked legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DE69615551T 1995-05-03 1996-05-02 Verwendung einer zubereitung enthaltend amoxycillin und clavulansäure zur herstellung eines medikaments zur behandlung von bakteriellen infektionen bei pädiatrischen patienten Revoked DE69615551T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9508989.2A GB9508989D0 (en) 1995-05-03 1995-05-03 Pharmaceutical formulations
GBGB9523655.0A GB9523655D0 (en) 1995-11-18 1995-11-18 Method of treatment
PCT/EP1996/001881 WO1996034605A1 (en) 1995-05-03 1996-05-02 Composition comprising amoxycillin and clavulanic acid

Publications (2)

Publication Number Publication Date
DE69615551D1 DE69615551D1 (de) 2001-10-31
DE69615551T2 true DE69615551T2 (de) 2002-04-25

Family

ID=26306975

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69615551T Revoked DE69615551T2 (de) 1995-05-03 1996-05-02 Verwendung einer zubereitung enthaltend amoxycillin und clavulansäure zur herstellung eines medikaments zur behandlung von bakteriellen infektionen bei pädiatrischen patienten

Country Status (33)

Country Link
EP (2) EP1013274A3 (de)
JP (1) JP3480939B2 (de)
KR (2) KR19990008253A (de)
CN (1) CN1104240C (de)
AP (1) AP851A (de)
AR (1) AR002993A1 (de)
AT (2) ATE206051T1 (de)
AU (1) AU712269C (de)
BG (2) BG64270B1 (de)
BR (1) BR9608270A (de)
CZ (1) CZ294434B6 (de)
DE (1) DE69615551T2 (de)
DK (1) DK0825860T3 (de)
DZ (1) DZ2028A1 (de)
EA (1) EA001878B1 (de)
ES (1) ES2160821T3 (de)
GR (1) GR3036722T3 (de)
HK (1) HK1009101A1 (de)
HU (2) HUP9801064A3 (de)
IL (1) IL118091A (de)
MA (1) MA24339A1 (de)
MY (1) MY127622A (de)
NO (1) NO975037L (de)
NZ (1) NZ308478A (de)
OA (1) OA10533A (de)
PE (1) PE20011100A1 (de)
PL (1) PL323103A1 (de)
PT (1) PT825860E (de)
RO (1) RO116343B1 (de)
SK (1) SK283794B6 (de)
TR (1) TR199701294T1 (de)
UA (1) UA46763C2 (de)
WO (1) WO1996034605A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR199800415T1 (en) 1995-09-07 1998-05-21 Smithkline Beecham Corporation Farmas�tik form�lasyon.
GB9617780D0 (en) * 1996-08-24 1996-10-02 Smithkline Beecham Plc Method of treatment
GB9815532D0 (en) 1998-07-17 1998-09-16 Lek Pharmaceutical & Cvhemical Pharmaceutical suspension formulation
US6177421B1 (en) 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
IE990159A1 (en) * 1999-02-26 2000-09-20 Fuisz Internat Ltd Storage Stable Amoxycillin and Clavulanate Suspension Composition.
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6156294A (en) * 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
EP1330236A2 (de) 2000-10-12 2003-07-30 Beecham Pharmaceuticals (Pte) Limited Amoxicillinhaltige arzneizusammensetzungen
CN100391456C (zh) * 2005-04-30 2008-06-04 南京师范大学 β-环糊精/阿莫西林包合物及其与克拉维酸钾的组合物及制备方法
DE102006007830A1 (de) * 2006-02-17 2007-08-30 Grünenthal GmbH Lagerstabile orale Darreichungsform von Amoxicillin und Clavulansäure
CN101406450B (zh) * 2007-10-12 2010-08-25 河南农业大学 复方阿莫西林油混悬注射液制备工艺
WO2013106601A1 (en) * 2012-01-10 2013-07-18 Michael Spector Pediatric oral suspension formulations of amoxicillin and clavulanate potassium and method for using same
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
CN106474122B (zh) * 2016-09-07 2020-04-14 湘北威尔曼制药股份有限公司 一种阿莫西林克拉维酸钾的药物组合物及其应用
CN108403676B (zh) * 2018-03-20 2020-08-21 中山大学 琥珀酸在提高细菌对抗生素敏感性方面的应用
CN116327760A (zh) * 2022-12-26 2023-06-27 南京臣功制药股份有限公司 一种阿莫西林克拉维酸钾缓释干混悬剂及其制备方法
CN117379378A (zh) * 2023-12-07 2024-01-12 山东金瑞生物科技有限公司 一种兽用复方阿莫西林可溶性粉及其制备工艺

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO984B1 (en) * 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
US4337887A (en) 1979-09-18 1982-07-06 Weyerhaeuser Company Reinforced half slotted container
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
EP0080862B1 (de) * 1981-12-02 1985-09-25 Beecham Group Plc Pharmazeutische Zubereitung die Beta-Lactam Antibiotika enthält
GB9007945D0 (en) 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416599D0 (en) 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
CZ345997A3 (cs) 1998-03-18
NZ308478A (en) 1999-04-29
ATE206051T1 (de) 2001-10-15
AT4423U1 (de) 2001-07-25
WO1996034605A1 (en) 1996-11-07
DK0825860T3 (da) 2001-11-19
EA199700354A1 (ru) 1998-04-30
BG102024A (en) 1998-07-31
BG64270B1 (bg) 2004-08-31
HK1009101A1 (en) 1999-05-28
EP1013274A3 (de) 2000-07-05
EP0825860B1 (de) 2001-09-26
IL118091A0 (en) 1996-09-12
IL118091A (en) 2004-07-25
KR19990008253A (ko) 1999-01-25
MY127622A (en) 2006-12-29
HU0201920D0 (de) 2002-08-28
EP0825860A1 (de) 1998-03-04
KR20050084498A (ko) 2005-08-26
CN1104240C (zh) 2003-04-02
RO116343B1 (ro) 2001-01-30
DZ2028A1 (fr) 2002-10-23
BG64271B1 (bg) 2004-08-31
PL323103A1 (en) 1998-03-16
PE20011100A1 (es) 2002-01-06
NO975037D0 (no) 1997-10-31
JP3480939B2 (ja) 2003-12-22
OA10533A (en) 2002-04-29
MA24339A1 (fr) 1998-07-01
BR9608270A (pt) 1999-05-04
PT825860E (pt) 2002-01-30
JPH11504911A (ja) 1999-05-11
DE69615551D1 (de) 2001-10-31
AU5814096A (en) 1996-11-21
NO975037L (no) 1997-10-31
EP1013274A2 (de) 2000-06-28
HUP9801064A2 (hu) 1998-08-28
GR3036722T3 (en) 2001-12-31
AU712269B2 (en) 1999-11-04
ES2160821T3 (es) 2001-11-16
AP851A (en) 2000-06-15
SK146297A3 (en) 1998-05-06
BG106763A (en) 2004-05-31
TR199701294T1 (xx) 1998-04-21
HUP9801064A3 (en) 1998-11-30
CN1189100A (zh) 1998-07-29
EA001878B1 (ru) 2001-10-22
UA46763C2 (uk) 2002-06-17
SK283794B6 (sk) 2004-01-08
AR002993A1 (es) 1998-05-27
CZ294434B6 (cs) 2005-01-12
AU712269C (en) 2002-06-06
AP9701122A0 (en) 1997-10-31

Similar Documents

Publication Publication Date Title
DE69615551T2 (de) Verwendung einer zubereitung enthaltend amoxycillin und clavulansäure zur herstellung eines medikaments zur behandlung von bakteriellen infektionen bei pädiatrischen patienten
ATE330593T1 (de) Verwendung von topiramat oder derivate davon zur herstellung eines arzneimittels zur behandlung von manisch-depressiven bipolaren störungen
PT78940A (de) Neue insulin-derivate verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE59309043D1 (de) Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und diese enthaltenden pharmazeutischen Präparaten
DE59207750D1 (de) Wegwerfhöschen und Verfahren zur Herstellung desselben
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE69617036T2 (de) Verwendung einer amoxicillin und clavulanat enthaltenden paediatrischen pharmazeutischen formulierung
ATA243992A (de) Verfahren zur herstellung von zur selektiven senkung des blutlipoidspiegels geeigneten arzneimittelpräparaten
ATE120954T1 (de) Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids.
DE69114653D1 (de) Sterilisierendes Gemisch und Verfahren zur Sterilisation.
ATE192646T1 (de) Verwendung eines stoffgemisches enthaltend alpha hydroxy organische säure zur herstellung eines arzneimittels zur behandlung von kleinen mundgeschwüren
AU4759390A (en) Method of medical treatment of alzheimer's disease
ATE196738T1 (de) Verwendung von immunglobulin-präparationen zur herstellung eines medikaments zur oralen verabreichung zur behandlung und prophylaxe chronischer schmerzzustände
DE69637449D1 (de) Verwendung von alpha-hydroxysäuren zur herstellung eines arzneimittels für die behandlung von entzündungen
DE58903917D1 (de) Verwendung des enzym-cofaktors nadph zur herstellung eines arzneimittels sowie daraus hergestelltes arzneimittel und verfahren zu seiner herstellung.
ATE135223T1 (de) Arzneimittel zur behandlung von hyperlipidämie und/oder atherosklerose
DE69120141T2 (de) Polymerkombiniertes Arzneimittel zur Magenbehandlung und Verfahren zu dessen Herstellung
DE69424563D1 (de) Verwendung von dimeticon zur herstellung eines arzneimittels zur behandlung von aphthen und stomatitis
ATA32291A (de) Verwendung eines bakterien-lysats zur herstellung eines medikaments zur behandlung der atopischen dermatitis
ATE183390T1 (de) Verwendung einer kombination von antineoplastonen zur herstellung eines arzneimittels zur behandlung der neurofibromatose
DE69515666D1 (de) VERWENDUNG VON GnRH-ANTAGONISTEN ZUR HERSTELLUNG EINES MEDIKAMENTS ZUR BEHANDLUNG GONADEN-STEROID ABHÄNGIGER ERKRANKUNGEN
DE69610045T2 (de) Verwendung eines Rohpflanzenextraktes zur Herstellung eines Arzneimittels zur Behandlung von HIV-Infektionen
DE69424415T2 (de) Verwendung von efaroxan und dessen derivaten zur herstellung eines arzneimittels zur behandlung parkinsonscher krankheit
DE4490853D2 (de) Behandlung von (Retro)viralen Erkrankungen sowie Verfahren zur Herstellung einer pharmazeutischen Zubereitung
DE69426622T2 (de) Verwendung von triazinverbindungen zur herstellung eines arzneimittels zur behandlung von erinnerungs-und lernstörungen

Legal Events

Date Code Title Description
8363 Opposition against the patent
8331 Complete revocation